Skip to main content
ES
v1.2
Log in
A

Alembic Pharma

ALEMBIC PHARMANSE
₹789.45-3.20 (-0.40%)as of 2026-10-16
Market Cap
₹15,549Cr.
P/E Ratio
20.8
P/B Ratio
2.73
EPS (TTM)
₹37.95
Day Range
₹771 – ₹793
Div Yield
1.47%
ROCE
12.6%
ROE
13.4%
52W Low: ₹63652W High: ₹998
Themes:💊 Pharma & CDMO
Descriptive screens built from published data — not investment advice.

At a glance

  • Sales have grown 9.0% a year over three years.
  • Debt is 0.25× its shareholders’ equity.

From reported financials and exchange prices. Descriptive only, not advice.

Alembic_Pharma — Price
Interval
||
Style
Failed: 503

Evenstocks Score

Middle third
6/ 10Overall
7/ 10Valuation
6/ 10Quality
6/ 10Fundamental
5/ 10Growth

Investment Checklist

Quick assessment based on key parameters
Performance
N/ATrailing return unavailable
Valuation
P/E 20.8P/E: 20.8 | P/B: 2.73
Growth
ModestSales CAGR — 3Y: 9% · 1Y: 14%
Profitability
ModerateROCE: 12.6% | ROE: 13.4%

Key Metrics

Valuation
PEG Ratio 0.74
Price / Sales 2.00x
Price / FCF 53.6x
Book Value ₹289
Margins & returns
Operating Margin 15%
Net Margin 8.9%
Return on Assets 7.9%

Frequently Asked Questions

MarketsPortfolioChart